Panelists explore the issue of drug pricing at ISPOR Europe 2019

ISPOR, the professional society for health economics and outcomes research-;explored the issue of drug pricing in the session, “Time for Change? Has the Time Come for the Pharma Industry to Accept Modest Prices?” [IP4].

From http://besthealthnews.com/2019/11/panelists-explore-the-issue-of-drug-pricing-at-ispor-europe-2019/?utm_source=rss&utm_medium=rss&utm_campaign=panelists-explore-the-issue-of-drug-pricing-at-ispor-europe-2019

from
https://healthnews010.wordpress.com/2019/11/05/panelists-explore-the-issue-of-drug-pricing-at-ispor-europe-2019/

From https://jamesjohnson10.blogspot.com/2019/11/panelists-explore-issue-of-drug-pricing.html

from
https://jamesjohnson10.wordpress.com/2019/11/05/panelists-explore-the-issue-of-drug-pricing-at-ispor-europe-2019/

From https://judywright2.blogspot.com/2019/11/panelists-explore-issue-of-drug-pricing.html

from
https://judywright2.wordpress.com/2019/11/05/panelists-explore-the-issue-of-drug-pricing-at-ispor-europe-2019/